Pilatus Biosciences
Phase 1Pilatus Biosciences pioneers innovative therapies using first-in-class antibodies and bifunctional proteins to target metabolic checkpoints, reprogramming the immune microenvironment to address cancer and immune-related diseases.
Founded
2020
Focus
AntibodiesBiologics
About
Pilatus Biosciences pioneers innovative therapies using first-in-class antibodies and bifunctional proteins to target metabolic checkpoints, reprogramming the immune microenvironment to address cancer and immune-related diseases.
Company Info
TypePrivate
Founded2020
LocationZurich, Switzerland
StagePhase 1
Contact
SIMILAR COMPANIES
3Brain
Pre-clinical · Zug
Baxiva
Pre-clinical · Zug
AC Bioscience
Pre-clinical · Lausanne
Abrinca Genomics
Pre-clinical · Zurich
AdipoGen
Pre-clinical · Liestal
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile